2Yokoyama Y, Sato S, Futagami M, et al. Prognostic significance of vascular endothelial growth factor and its receptors in endometrial carcinoma. Gynecol Oncol,2000,77:413-418.
3Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med, 2006,203 : 2201- 2213.
4Wang J ,Shiozawa Y ,Wang J,et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem, 2008,283 : 4283 -4294.
5Miao Z,Luker KE,Summers BC,et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor- associated vasculature. Proc Natl Acad Sci U S A,2007, 104: 15735-15740.
6Schutyser E, Su Y, Yu Y, et al. Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma ceils. Eur Cytokine Netw,2007,18 : 59 -70.
7Goldmann T, Dromann D, Radtke J, et al. CXCR7 transcription in human non-small eell lung cancer and tumor-free lung tissues; possible regulation upon chemotherapy. Virchows Arch ,2008,452: 347-348.
8Meijer J,Ogink J,Roos E. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo. Br J Cancer,2008,99 : 1493-1501.
9Marechal R, Demetter P, Nagy N, et al. High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma. Br J Cancer,2009,100 : 1444-1451.
10Riediger H, Keck T, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg,2009,13 : 1337-1344.
2Miyanishi N, Suzuki Y,Simizu S, et al. Involvement of auto crine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion[J]. Biochem Biophys Res Commun, 2010,403(1) :154-159.
3Oliveira Frick V, Rubie C, Ghadjar P, et al. Changes in CXCL12/CXCR4 ehemokine expression during onset of color- ectal malignancies[J]. Tumour Biol,2011,32(1):189-196.
4Balabanian K, Lagane B, Infentino S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphovytes[J]. J Biol Chem, 2005,280 (42) :35760-35766.
5KawasakiH,AltieriDC,Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer [J]. Cancer Res,1998,58(22):5071-5074.
6Chen JC, Chang YW, Hong CC, et al. The role of the VEGF-C/ VEGFRs axis in tumor progression and therapy[J]. Int J Mol Sci, 2012,14(1) :88-107.
7Zhan H, Liang H, Liu X, et al. Expression of Racl, HIF-1α and VEGF in gastric carcinoma:correlation with angiogenesis and prognosis[J]. Onkologie, 2013,36 (3) : 102 107.
8Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development [J]. J Exp Med, 2006, 203 (9) : 2201-2213.
9Yates TJ, Knapp J, Gosalbez M, et al. C X C chemokine receptor 7: a functionally associated molecular marker for bladder cancer[J]. Cancer, 2013,119(1) : 61-71.
